Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification
Y Fu, J Yu, F Li, S Ge - Journal of Experimental & Clinical Cancer …, 2022 - Springer
Metabolites are intermediate products of cellular metabolism catalysed by various enzymes.
Metabolic remodelling, as a biochemical fingerprint of cancer cells, causes abnormal …
Metabolic remodelling, as a biochemical fingerprint of cancer cells, causes abnormal …
Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules
Efficient delivery of therapeutic and diagnostic molecules to the cells and tissues is a difficult
challenge. The cellular membrane is very effective in its role as a selectively permeable …
challenge. The cellular membrane is very effective in its role as a selectively permeable …
[HTML][HTML] On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
Cancer is the second leading cause of death affecting nearly one in two people, and the
appearance of new cases is projected to rise by> 70% by 2030. To effectively combat the …
appearance of new cases is projected to rise by> 70% by 2030. To effectively combat the …
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases
W Yao, X Hu, X Wang - Signal Transduction and Targeted Therapy, 2024 - nature.com
Histone post-translational modifications (HPTMs), as one of the core mechanisms of
epigenetic regulation, are garnering increasing attention due to their close association with …
epigenetic regulation, are garnering increasing attention due to their close association with …
Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications
Z Guo, H Peng, J Kang, D Sun - Biomedical reports, 2016 - spandidos-publications.com
Abstract Cell-penetrating peptides (CPPs), also known as protein transduction domains, are
a class of diverse peptides with 5‑30 amino acids. CPPs are divided into cationic …
a class of diverse peptides with 5‑30 amino acids. CPPs are divided into cationic …
Drug delivery and release systems for targeted tumor therapy
D Böhme, AG Beck‐Sickinger - Journal of Peptide Science, 2015 - Wiley Online Library
Most toxic agents currently used for chemotherapy show a narrow therapeutic window,
because of their inability to distinguish between healthy and cancer cells. Targeted drug …
because of their inability to distinguish between healthy and cancer cells. Targeted drug …
Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates
Specifically addressing cell surface molecules on cancer cells facilitates targeted cancer
therapies that offer the potential to selectively destroy malignant cells, while sparing healthy …
therapies that offer the potential to selectively destroy malignant cells, while sparing healthy …
NGR-peptide− drug conjugates with dual targeting properties
Peptides containing the asparagine-glycine-arginine (NGR) motif are recognized by
CD13/aminopeptidase N (APN) receptor isoforms that are selectively overexpressed in …
CD13/aminopeptidase N (APN) receptor isoforms that are selectively overexpressed in …
Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies
P Limonta, M Manea - Cancer treatment reviews, 2013 - Elsevier
Prostate cancer is androgen-dependent in its early stages and androgen deprivation
therapy represents the most effective first-line therapeutic approach. However, after an initial …
therapy represents the most effective first-line therapeutic approach. However, after an initial …
Enhanced in vitro antitumor activity of GnRH-III-daunorubicin bioconjugates influenced by sequence modification
Receptors for gonadotropin releasing hormone (GnRH) are highly expressed in various
human cancers including breast, ovarian, endometrial, prostate and colorectal cancer …
human cancers including breast, ovarian, endometrial, prostate and colorectal cancer …